Development of thoracic sarcoid reactions associated with complete response to anti‐PD‐1 therapy in a patient with advanced cutaneous squamous cell carcinoma-Reference-Cited by-同舟云学术

Development of thoracic sarcoid reactions associated with complete response to anti‐PD‐1 therapy in a patient with advanced cutaneous squamous cell carcinoma

Published:2021-12-02 Issue:S1 Volume:36 Page:35-40
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Gambichler T.¹^ORCID,Philippou S.²,Scheel C.H.¹,Susok L.¹

Affiliation:

1. Skin Cancer Center Department of Dermatology Ruhr‐University Bochum Bochum Germany

2. Department of Pathology and Cytology Augusta Kliniken Bochum Hattingen Bochum Germany

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.17401

Reference15 articles.

1. Fortgeschrittene Basalzell- und Plattenepithelkarzinome der Haut

2. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial

3. Meta‐analysis of immune‐related adverse events of immune checkpoint inhibitor therapy in cancer patients

4. Pembrolizumab for cutaneous squamous cell carcinoma: Report of a case of inoperable squamous cell carcinoma with complete response to pembrolizumab complicated by granulomatous inflammation

5. Particular findings on lung CT in patients undergoing immunotherapy for bronchogenic carcinoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors in advanced and recurrent/metastatic cervical cancer;Frontiers in Oncology;2022-10-06

2. The Meaning of Lymphadenopathies During Adjuvant Durvalumab After Chemoradiotherapy for Lung Cancer: Thinking Beyond Disease Progression;Cureus;2022-07-11

3. Cemiplimab/pembrolizumab;Reactions Weekly;2022-02